SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001494650-24-000170
Filing Date
2024-12-18
Accepted
2024-12-18 16:35:12
Documents
1
Period of Report
2024-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1734557705.html 4  
1 FORM 4 wk-form4_1734557705.xml 4 4321
  Complete submission text file 0001494650-24-000170.txt   5759
Mailing Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067
Business Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Issuer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1020 STONY HILL ROAD, SUITE 300 YARDLEY PA 19067
Business Address
Mahmoud Ramy A (Reporting) CIK: 0001718725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38241 | Film No.: 241559769